C

Clene
D

CLNN

5.35000
USD
-0.01
(-0.19%)
Market Open
Volume
182
EPS
0
Div Yield
0
P/E
-2
Market Cap
34,614,858
News

Title: Clene Inc.

Sector: Consumer Defensive
Industry: Packaged Foods
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercializationof dietary supplements (Supplements).